Showing 8281-8290 of 21409 results for "".
Balancing Blood Sugar: The Role of Yoga in Diabetes Management
https://reachmd.com/programs/what-your-patients-are-talking-about/tbd/15490/Tune in to find out how yoga can help lower blood sugar levels in patients with type 2 diabetes.Epithelial Cytokines Drive Type 2 Inflammation in Eosinophilic Esophagitis
https://reachmd.com/programs/innovations-in-medicine/epithelial-cytokines-drive-type-2-inflammation-in-eosinophilic-esophagitis/61115/Eosinophilic esophagitis (EoE) is a disease that can begin before eosinophilic inflammation becomes apparent on biopsy.1-5 The esophageal epithelium responds to food antigens, aeroallergens, and other environmental insults by releasing epithelial cytokines which initiate the downstream type 2 inflamThe Diabetes Infrastructure: Regulation & Reimbursement
https://reachmd.com/programs/diabetes-discourse/the-diabetes-infrastructure-regulation-reimbursement/4796/The prevalence of diabetes complications and its associated costs represent an infrastructure that may be virtually unsustainable in the near future. Join host Dr. Steven Edelman and his guest, editor-in-chief of the diabetes publications Closer Look and Diabetes Close Up, Kelly Close, as they discuObesity, Diabetes and the Metabolic Syndrome
https://reachmd.com/programs/lipid-luminations/obesity-diabetes-and-the-metabolic-syndrome/6706/Host Dr. Alan S. Brown is joined by Kevin C. Maki, PhD, FNLA, Chief Science Officer of Biofortis Clinical Research. Dr. Maki will review obesity, metabolic syndrome and type 2 diabetes mellitus as they are all insulin resistant states and are often characterized by atherogenic dyslipidemia or theCurrent Trends and Treatment Goals for Diabetes
https://reachmd.com/programs/focus-on-pharmacy/current-trends-and-treatment-goals-for-diabetes/3531/How can we best optimize pharmacotherapy for patients with Type 2 diabetes? What are the main treatment barriers to keep in mind, and what are the most common comorbidities that we might be able to treat concurrently with diabetes therapy? Dr. Susan Cornell, assistant professor of pharmacy practiceCounseling Adolescents About Long-Acting Reversible Contraception
https://reachmd.com/programs/advances-in-womens-health/counseling-adolescents-about-long-acting-reversible-contraception/48738/Long-acting reversible contraceptives are recommended as first-line contraceptive options for adolescents because of their safety and effectiveness. However, concerns about future fertility, pain, and the insertion process can make counseling patients on these methods challenging. That's why Dr. SheNavigating Chronic Anticoagulation Reversal in Cardiothoracic Surgery
https://reachmd.com/programs/heart-matters/chronic-anticoagulation-reversal-cardiothoracic-surgery/57166/When cardiothoracic surgery can’t wait, chronic anticoagulation can further complicate an already complex clinical picture. In this conversation with Dr. Brian McDonough, Dr. Ahmet Kilic explores the factors that can help inform anticoagulation reversal decisions in time-sensitive scenarios. Dr.How Do I Advance DE&I in My Practice?
https://reachmd.com/topics/practice-development/how-do-i-advance-dei-in-my-practice/35212/The Link Between Diabetes and Sleep Apnea
https://reachmd.com/programs/diabetes-discourse/the-link-between-diabetes-and-sleep-apnea/4601/Type 2 diabetes and obstructive sleep apnea have been shown to have a close relationship. Join host Dr. Steven Edelman and his guest, sleep specialist and pulmonologist Dr. Shazia Jamil, as they discuss the diagnosis and treatments of obstructive sleep apnea including continuous positive airway presDo Women With Diabetes Have a Greater Risk of Cardiovascular Disease?
https://reachmd.com/programs/diabetes-discourse/do-women-with-diabetes-have-a-greater-risk-of-cardiovascular-disease/5946/What is known about the relationship between glucose control and cardiovascular disease in diabetes? The recent Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial provides some interesting results on the relationship between type 2 diabetes and silent m